Modern strategies for the treatment of psychoemotional stress in patients with heart coronary disease after myocardial revascularization

Coronary heart disease in many countries of the world, including in Ukraine, causes high rates of morbidity, disability and mortality. The study of factors affecting the occurrence, course, prognosis and effectiveness of drug therapy for coronary artery disease is important and relevant. One of such...

Full description

Saved in:
Bibliographic Details
Main Authors: B. M. Holdovskyy, I. V. Filimonova, S. O. Potalov, K. V. Serikov, D. V. Lelyuk, R. V. Filimonov
Format: Article
Language:English
Published: Zaporizhzhia State Medical and Pharmaceutical University 2019-04-01
Series:Сучасні медичні технології
Subjects:
Online Access:https://zmapo-journal.com/index.php/journal/article/view/129
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846093137612636160
author B. M. Holdovskyy
I. V. Filimonova
S. O. Potalov
K. V. Serikov
D. V. Lelyuk
R. V. Filimonov
author_facet B. M. Holdovskyy
I. V. Filimonova
S. O. Potalov
K. V. Serikov
D. V. Lelyuk
R. V. Filimonov
author_sort B. M. Holdovskyy
collection DOAJ
description Coronary heart disease in many countries of the world, including in Ukraine, causes high rates of morbidity, disability and mortality. The study of factors affecting the occurrence, course, prognosis and effectiveness of drug therapy for coronary artery disease is important and relevant. One of such factors is the psychological disorders of the anxiety-depressive spectrum, which often occur in patients with myocardial infarction and after coronary artery bypass grafting; therefore, such patients should be carefully examined for affective disorders and receive appropriate drug therapy. Purpose of the study. Improvement of diagnosis and optimization of patients treatment with ischemic heart disease with concomitant anxiety-depressive disorders after myocardial revascularization. Material and methods. The results of the study are based on survey data and dynamic observation of 95 patients with coronary heart disease, postinfarction cardiosclerosis after myocardial revascularization. The patients underwent examination during the initial examination and after 12 weeks. Results of the study and their discussion. In the study of the psychoemotional state in the patients examined after the treatment, a significant decrease in anxiety manifestations was revealed by 36,4% against the group without fluvoxamine, where there was no significant difference before and after treatment. The manifestations of depressive disorder in the fluvoxamine group significantly decreased after treatment by 45,8 (HADS) and by 47,0% (Beck), in contrast to the group without fluvoxamine, where there was no significant difference before and after treatment. Conclusions. Thus, it has been proved that with the addition of fluvoxamine to combined therapy for patients with ischemic heart disease, postinfarction cardiosclerosis after revascularization of the myocardium shows a more pronounced decrease in the manifestations of anxiety-depressive disorder.
format Article
id doaj-art-2d0edd6a9c1d49a89781272ad0a6815d
institution Kabale University
issn 2072-9367
language English
publishDate 2019-04-01
publisher Zaporizhzhia State Medical and Pharmaceutical University
record_format Article
series Сучасні медичні технології
spelling doaj-art-2d0edd6a9c1d49a89781272ad0a6815d2025-01-02T18:55:14ZengZaporizhzhia State Medical and Pharmaceutical UniversityСучасні медичні технології2072-93672019-04-011(40)253010.34287/MMT.1(40).2019.4129Modern strategies for the treatment of psychoemotional stress in patients with heart coronary disease after myocardial revascularizationB. M. Holdovskyy0I. V. Filimonova1S. O. Potalov2K. V. Serikov3D. V. Lelyuk4R. V. Filimonov5State institution "Zaporizhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine"State institution "Zaporizhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine"State institution "Zaporizhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine"State institution "Zaporizhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine"State institution "Zaporizhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine"State institution "Zaporizhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine"Coronary heart disease in many countries of the world, including in Ukraine, causes high rates of morbidity, disability and mortality. The study of factors affecting the occurrence, course, prognosis and effectiveness of drug therapy for coronary artery disease is important and relevant. One of such factors is the psychological disorders of the anxiety-depressive spectrum, which often occur in patients with myocardial infarction and after coronary artery bypass grafting; therefore, such patients should be carefully examined for affective disorders and receive appropriate drug therapy. Purpose of the study. Improvement of diagnosis and optimization of patients treatment with ischemic heart disease with concomitant anxiety-depressive disorders after myocardial revascularization. Material and methods. The results of the study are based on survey data and dynamic observation of 95 patients with coronary heart disease, postinfarction cardiosclerosis after myocardial revascularization. The patients underwent examination during the initial examination and after 12 weeks. Results of the study and their discussion. In the study of the psychoemotional state in the patients examined after the treatment, a significant decrease in anxiety manifestations was revealed by 36,4% against the group without fluvoxamine, where there was no significant difference before and after treatment. The manifestations of depressive disorder in the fluvoxamine group significantly decreased after treatment by 45,8 (HADS) and by 47,0% (Beck), in contrast to the group without fluvoxamine, where there was no significant difference before and after treatment. Conclusions. Thus, it has been proved that with the addition of fluvoxamine to combined therapy for patients with ischemic heart disease, postinfarction cardiosclerosis after revascularization of the myocardium shows a more pronounced decrease in the manifestations of anxiety-depressive disorder.https://zmapo-journal.com/index.php/journal/article/view/129anxiety-depressive disordersischemic heart diseaserevascularization of myocardiumantidepressants
spellingShingle B. M. Holdovskyy
I. V. Filimonova
S. O. Potalov
K. V. Serikov
D. V. Lelyuk
R. V. Filimonov
Modern strategies for the treatment of psychoemotional stress in patients with heart coronary disease after myocardial revascularization
Сучасні медичні технології
anxiety-depressive disorders
ischemic heart disease
revascularization of myocardium
antidepressants
title Modern strategies for the treatment of psychoemotional stress in patients with heart coronary disease after myocardial revascularization
title_full Modern strategies for the treatment of psychoemotional stress in patients with heart coronary disease after myocardial revascularization
title_fullStr Modern strategies for the treatment of psychoemotional stress in patients with heart coronary disease after myocardial revascularization
title_full_unstemmed Modern strategies for the treatment of psychoemotional stress in patients with heart coronary disease after myocardial revascularization
title_short Modern strategies for the treatment of psychoemotional stress in patients with heart coronary disease after myocardial revascularization
title_sort modern strategies for the treatment of psychoemotional stress in patients with heart coronary disease after myocardial revascularization
topic anxiety-depressive disorders
ischemic heart disease
revascularization of myocardium
antidepressants
url https://zmapo-journal.com/index.php/journal/article/view/129
work_keys_str_mv AT bmholdovskyy modernstrategiesforthetreatmentofpsychoemotionalstressinpatientswithheartcoronarydiseaseaftermyocardialrevascularization
AT ivfilimonova modernstrategiesforthetreatmentofpsychoemotionalstressinpatientswithheartcoronarydiseaseaftermyocardialrevascularization
AT sopotalov modernstrategiesforthetreatmentofpsychoemotionalstressinpatientswithheartcoronarydiseaseaftermyocardialrevascularization
AT kvserikov modernstrategiesforthetreatmentofpsychoemotionalstressinpatientswithheartcoronarydiseaseaftermyocardialrevascularization
AT dvlelyuk modernstrategiesforthetreatmentofpsychoemotionalstressinpatientswithheartcoronarydiseaseaftermyocardialrevascularization
AT rvfilimonov modernstrategiesforthetreatmentofpsychoemotionalstressinpatientswithheartcoronarydiseaseaftermyocardialrevascularization